1. Home
  2. TELO vs ULBI Comparison

TELO vs ULBI Comparison

Compare TELO & ULBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TELO
  • ULBI
  • Stock Information
  • Founded
  • TELO 2021
  • ULBI 1990
  • Country
  • TELO United States
  • ULBI United States
  • Employees
  • TELO N/A
  • ULBI N/A
  • Industry
  • TELO
  • ULBI Industrial Machinery/Components
  • Sector
  • TELO
  • ULBI Miscellaneous
  • Exchange
  • TELO NYSE
  • ULBI Nasdaq
  • Market Cap
  • TELO 154.1M
  • ULBI 158.1M
  • IPO Year
  • TELO 2024
  • ULBI 1992
  • Fundamental
  • Price
  • TELO $4.69
  • ULBI $7.82
  • Analyst Decision
  • TELO
  • ULBI Strong Buy
  • Analyst Count
  • TELO 0
  • ULBI 1
  • Target Price
  • TELO N/A
  • ULBI $14.00
  • AVG Volume (30 Days)
  • TELO 225.7K
  • ULBI 53.8K
  • Earning Date
  • TELO 02-12-2025
  • ULBI 02-13-2025
  • Dividend Yield
  • TELO N/A
  • ULBI N/A
  • EPS Growth
  • TELO N/A
  • ULBI 115.20
  • EPS
  • TELO N/A
  • ULBI 0.54
  • Revenue
  • TELO N/A
  • ULBI $165,152,000.00
  • Revenue This Year
  • TELO N/A
  • ULBI $3.26
  • Revenue Next Year
  • TELO N/A
  • ULBI $36.05
  • P/E Ratio
  • TELO N/A
  • ULBI $14.52
  • Revenue Growth
  • TELO N/A
  • ULBI 9.95
  • 52 Week Low
  • TELO $3.11
  • ULBI $6.63
  • 52 Week High
  • TELO $20.72
  • ULBI $13.39
  • Technical
  • Relative Strength Index (RSI)
  • TELO 50.83
  • ULBI 56.13
  • Support Level
  • TELO $4.05
  • ULBI $7.15
  • Resistance Level
  • TELO $5.17
  • ULBI $7.83
  • Average True Range (ATR)
  • TELO 0.45
  • ULBI 0.28
  • MACD
  • TELO 0.03
  • ULBI 0.07
  • Stochastic Oscillator
  • TELO 58.62
  • ULBI 82.56

About TELO TELOMIR PHARMACEUTICALS INC

Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company leading the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.

About ULBI Ultralife Corporation

Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

Share on Social Networks: